Top St. Louis, MO Biotech Startups (23)
Tansna Therapeutics is a developer of an oral anticonvulsant agent that reduces seizure frequency in patients with epilepsy.
Mobius Therapeutics is an early-stage venture focused on ophthalmic surgery solutions.
NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs.
GlucanBio, an early stage company that repurposes non-food biomass into high-value chemicals and biomaterials
As of September 2014, G-Biosciences management system governing the manufacture of our products is ISO9001:2008 certified. For more details on G-Biosciences biotechnology and life science research products click the products tab. Geno Technology, Inc. was founded in 1994 with a vision to simplify life science research. Our primary goal was to target the key techniques of protein research and find affordable methods...
Wugen is a developer of a novel CAR-T therapy platform intended for T-Cell Malignancies.
EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders.
Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.
Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy.
APT Therapeutics is a Biotechnology company located in 4041 Forest Park Ave., St. Louis, MO, United States.
Confluence is a contract research organization providing mechanistic enzymology, target validation, characterization, and more.
BioSTL builds regional capacity and fosters collaborative efforts to advance innovation,
Digital health company with holographic AR platform for intraprocedural clinical use.
Partek is a software company that provides easy-to-use genomic data analysis solutions for scientists.
OpenCell Technologies provides efficient, high-throughput and scalable transfection tools to researchers in the Life Sciences.
Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases.
C₂N Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around bringing accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring. Its lead commercial product, the PrecivityAD™ blood...
Readout is a sensor biomarker startup that enables sustained metabolic optimization of patients and self-care consumers with fat oxidation biofeedback in breath. We introduced Biosense in 2020 as a Class 1 medical device for in-home behavior modification. Our digital experience allows "dosing" of ketosis with a patented deep lung sampling technology in a precision nutrition journey from weight loss to...
